Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia
Need for medical guidance before using for investigational purposes (oral/injectable) Long term, consistent use is needed for any possible results Always consult a qualified healthcare provider before starting peptide-based therapies
There is no human trial of the injectable TB-500 fragment for tendon, muscle, or systemic recovery
Therefore, cycling such as 6 weeks on, 3 weeks off helps reduce potential risks
Expected results and realistic timelines Setting realistic expectations is important for maintaining protocol adherence